person

Hsien-Yuan Lane, MD.PhD.

Hsien-Yuan LaneHsien-Yuan Lane, MD,PhDHsien-yuan Lane, MD,PHDHsien-yuan Lane, MD,PhD
as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Principal Investigator, Study Director
KOL signal score 5
0 publications · 0 high-value
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
Dept. of Psychiatry, China Medical University Hospital, Taichung, Taiwan
Roles
Principal Investigator, Study Director
KOL signal
5
Publications
0 (0 high-value)
Trial investigator
yes

Trials led

5
Expanding Rapid Ascertainment Network of Schizophrenia Families in Taiwan
NCT01249079—Unknown
Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia
NCT00328276Phase 2Completed
Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia
NCT01047592Phase 2Completed
GlyT-1 Inhibitor Treatment for Refractory Schizophrenia
NCT01251055Phase 2Completed
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
NCT00491569Phase 2Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
STUDY_DIRECTOR
Expanding Rapid Ascertainment Network of Schizophrenia Families in Taiwan
trial
Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia
trial
PRINCIPAL_INVESTIGATOR
Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia
trial
GlyT-1 Inhibitor Treatment for Refractory Schizophrenia
trial
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
trial